Menu Search
Equities

INOVIQ Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
EGQ0:MUN

INOVIQ Ltd

Actions
  • Price (EUR)0.21
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-24.46%
  • Beta1.9388
Data delayed at least 15 minutes, as of Feb 12 2026 07:16 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

INOVIQ Ltd is an Australia-based biotechnology company developing diagnostics and therapeutics for cancer. The Company's commercialized products include EXO-NET exosome isolation technology for biomarker discovery and diagnostics development, and the hTERT test as an adjunct test for bladder cancer. The Company is also advancing clinical-stage diagnostics for the detection and monitoring of ovarian and breast cancers, and early-stage exosome therapeutics for solid tumors.

  • Revenue in AUD (TTM)959.32k
  • Net income in AUD-6.93m
  • Incorporated1983
  • Employees85.00
  • Location
    INOVIQ Ltd23 Normanby Road, Notting HillNEDLANDS 3168AustraliaAUS
  • Phone+61 39548-7586
  • Fax+61 89388-7559
  • Websitehttps://www.inoviq.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.